This report contains market size and forecasts of Ulcerative Colitis Medicine in Global, including the following market information:
Global Ulcerative Colitis Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ulcerative Colitis Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5-Aminosalicylic Acid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ulcerative Colitis Medicine include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ulcerative Colitis Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ulcerative Colitis Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ulcerative Colitis Medicine Market Segment Percentages, by Type, 2021 (%)
5-Aminosalicylic Acid
Corticosteroids
Immunomodulator Drugs
Biologics
Global Ulcerative Colitis Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ulcerative Colitis Medicine Market Segment Percentages, by Application, 2021 (%)
Ulcerative Proctitis
Proctosigmoiditis
Left-Sided Colitis
Pancolitis
Acute Severe Ulcerative Colitis
Global Ulcerative Colitis Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ulcerative Colitis Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ulcerative Colitis Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ulcerative Colitis Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Cipla
Sun Pharm
Allergan
Teva Pharmaceutical